Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Tofacitinib Citrate in Plaque psoriasis: NCT07261306 Clinical Landscape Report 2026
15 October 2026
NCT07261306 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Clobetasol Propionate in Dermatitis, Atopic: CTRI/2025/12/098406 Clinical Landscape Report 2026
15 October 2026
CTRI/2025/12/098406 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Drotokibart in Dermatitis, Atopic: NCT07264335 Clinical Landscape Report 2026
15 October 2026
NCT07264335 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Picankibart in Plaque psoriasis: NCT07265284 Clinical Landscape Report 2026
15 October 2026
NCT07265284 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tapinarof in Dermatitis, Atopic: NCT07265479 Clinical Landscape Report 2026
15 October 2026
NCT07265479 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anti-LILRA6 CAR-T cells(Second Affiliated Hospital Zhejiang University College of) in Recurrent Acute Leukemia: NCT07263906 Clinical Landscape Report 2026
15 October 2026
NCT07263906 clinical landscape for Recurrent Acute Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07264010 Clinical Landscape Report 2026
15 October 2026
NCT07264010 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ramantamig in Relapse multiple myeloma: NCT07266441 Clinical Landscape Report 2026
15 October 2026
NCT07266441 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dexmedetomidine Hydrochloride in Multiple Sclerosis, Relapsing-Remitting: NCT07263607 Clinical Landscape Report 2026
15 October 2026
NCT07263607 clinical landscape for Multiple Sclerosis, Relapsing-Remitting: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
Albumin-Bound Paclitaxel in Platinum-Resistant Ovarian Carcinoma: NCT07265739 Clinical Landscape Report 2026
15 October 2026
NCT07265739 clinical landscape for Platinum-Resistant Ovarian Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
CD33 FPBMC(University of Virginia) in Acute Myeloid Leukemia: NCT07270978 Clinical Landscape Report 2026
15 October 2026
NCT07270978 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rivaroxaban in Pulmonary Embolism: NCT07270263 Clinical Landscape Report 2026
15 October 2026
NCT07270263 clinical landscape for Pulmonary Embolism: endpoints, sponsor, phase, geography, readouts, asset context and development white space.